Related Experiment Video
Updated: Dec 10, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus
Soo-Yeon Choi1, Seung-Hyun Ko1
1Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Abstract:
Glucose-lowering medication and lifestyle modification are essential for optimal glycemic control in patients with type 2 diabetes mellitus (T2DM). However, glucose-lowering agents, particularly insulin and insulin secretagogues, may cause hypoglycemia, which has multiple negative effects on the cardiovascular (CV) system and may cause death. Previous studies using institutional data from the Korean Nationwide Health Insurance database have consistently found a causal relationship between severe hypoglycemia and CV outcomes and mortality. Screening for high-risk patients, appropriate management, and intensive individualized education are the most effective measures and essential for the prevention of harmful hypoglycemic events. Based on identified risk factors that predict severe hypoglycemia, we developed an 1-year risk prediction model for severe hypoglycemia that can be used in clinical settings. In this review, we describe the current understanding of severe hypoglycemia and the clinical implications in patients with T2DM. Furthermore, we highlight the importance of intensive individualized education for high-risk patients and the risk prediction model to reduce severe hypoglycemia.
Insights
Severe hypoglycemia in type 2 diabetes mellitus (T2DM) increases cardiovascular risks and mortality. A new risk prediction model and education can help prevent these dangerous events.
Area of Science:
- Endocrinology
- Cardiology
- Public Health
Background:
- Type 2 diabetes mellitus (T2DM) management requires glycemic control through medication and lifestyle changes.
- Glucose-lowering agents, especially insulin, can lead to hypoglycemia, posing significant cardiovascular (CV) risks and mortality.
- Prior research confirms a link between severe hypoglycemia and adverse CV outcomes in T2DM patients.
Purpose of the Study:
- To review the current understanding of severe hypoglycemia in T2DM.
- To highlight the clinical implications of severe hypoglycemia.
- To introduce a novel 1-year risk prediction model for severe hypoglycemia in T2DM patients.
Main Methods:
- Literature review on severe hypoglycemia in T2DM.
- Analysis of risk factors for severe hypoglycemia.
- Development of a clinical risk prediction model for severe hypoglycemia.
Main Results:
- Severe hypoglycemia is causally linked to CV outcomes and mortality in T2DM.
- Identified risk factors enable the development of a predictive model.
- Intensive, individualized education is crucial for high-risk patients.
Conclusions:
- A new risk prediction model can identify T2DM patients at high risk for severe hypoglycemia.
- Implementing this model and targeted education can reduce severe hypoglycemic events.
- Proactive management is essential for mitigating hypoglycemia-related CV risks and mortality in T2DM.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

